IDev, YMed to distribute VascuTrak 2 catheter
IDev Technologies, a developer of minimally invasive stent systems for the treatment of peripheral vascular and non-vascular diseases, has entered an exclusive distribution agreement with YMed for sales of the VascuTrak 2 Focal Force PTA Catheter in North American and select European markets.
The Houston-based IDev said that VascuTrak 2 was engineered for the dilatation of stenoses of the peripheral vasculature and is available in a broad range of diameter sizes and lengths to address this challenging anatomy. It is approved for use in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries and for the treatment of obstructive lesions of native synthetic arteriovenous dialysis fistulae.
The Focal Force design concentrates the forces from balloon inflation along two axial dimensions to achieve safe and effective dilatation of both soft and calcified lesions at lower balloon inflation pressures. As a result, it is believed that the incidence of barotrauma may be reduced, the San Diego-based YMed said.
The Houston-based IDev said that VascuTrak 2 was engineered for the dilatation of stenoses of the peripheral vasculature and is available in a broad range of diameter sizes and lengths to address this challenging anatomy. It is approved for use in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries and for the treatment of obstructive lesions of native synthetic arteriovenous dialysis fistulae.
The Focal Force design concentrates the forces from balloon inflation along two axial dimensions to achieve safe and effective dilatation of both soft and calcified lesions at lower balloon inflation pressures. As a result, it is believed that the incidence of barotrauma may be reduced, the San Diego-based YMed said.